These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38927430)
21. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease. Miao Y; Meng H Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911 [TBL] [Abstract][Full Text] [Related]
23. α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease. Ryan BJ; Lourenço-Venda LL; Crabtree MJ; Hale AB; Channon KM; Wade-Martins R Free Radic Biol Med; 2014 Feb; 67():58-68. PubMed ID: 24148766 [TBL] [Abstract][Full Text] [Related]
24. Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity. Stoll AC; Sortwell CE Neurobiol Dis; 2022 Sep; 171():105804. PubMed ID: 35764290 [TBL] [Abstract][Full Text] [Related]
25. Mitochondrial ROS-mediated post-transcriptional regulation of α-synuclein through miR-7 and miR-153. Je G; Kim YS Neurosci Lett; 2017 Nov; 661():132-136. PubMed ID: 28986122 [TBL] [Abstract][Full Text] [Related]
26. HtrA2 regulates α-Synuclein-mediated mitochondrial reactive oxygen species production in the mitochondria of microglia. Nam MK; Seong Y; Jeong GH; Yoo SA; Rhim H Biochem Biophys Res Commun; 2023 Jan; 638():84-93. PubMed ID: 36442236 [TBL] [Abstract][Full Text] [Related]
29. GV-971 attenuates α-Synuclein aggregation and related pathology. Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872 [TBL] [Abstract][Full Text] [Related]
30. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP Wu KC; Liou HH; Lee CY; Lin CJ Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389 [TBL] [Abstract][Full Text] [Related]
31. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease. Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T Front Immunol; 2021; 12():719807. PubMed ID: 34691027 [TBL] [Abstract][Full Text] [Related]
32. Neuroprotection of Andrographolide against Neurotoxin MPP Prasertsuksri P; Kraokaew P; Pranweerapaiboon K; Sobhon P; Chaithirayanon K Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239873 [TBL] [Abstract][Full Text] [Related]
33. The Interplay between α-Synuclein and Microglia in α-Synucleinopathies. Deyell JS; Sriparna M; Ying M; Mao X Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768798 [TBL] [Abstract][Full Text] [Related]
34. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death. Kaul S; Anantharam V; Kanthasamy A; Kanthasamy AG Brain Res Mol Brain Res; 2005 Sep; 139(1):137-52. PubMed ID: 15978696 [TBL] [Abstract][Full Text] [Related]
35. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production. Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083 [TBL] [Abstract][Full Text] [Related]
36. Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson's disease. Jakova E; Moutaoufik MT; Lee JS; Babu M; Cayabyab FS Transl Neurodegener; 2022 Feb; 11(1):9. PubMed ID: 35139916 [TBL] [Abstract][Full Text] [Related]
37. Alpha-synuclein activates BV2 microglia dependent on its aggregation state. Hoffmann A; Ettle B; Bruno A; Kulinich A; Hoffmann AC; von Wittgenstein J; Winkler J; Xiang W; Schlachetzki JCM Biochem Biophys Res Commun; 2016 Oct; 479(4):881-886. PubMed ID: 27666480 [TBL] [Abstract][Full Text] [Related]
38. Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model. Sommer A; Fadler T; Dorfmeister E; Hoffmann AC; Xiang W; Winner B; Prots I J Neuroinflammation; 2016 Jun; 13(1):174. PubMed ID: 27364890 [TBL] [Abstract][Full Text] [Related]
39. Activating transcription factor-4 promotes neuronal death induced by Parkinson's disease neurotoxins and α-synuclein aggregates. Demmings MD; Tennyson EC; Petroff GN; Tarnowski-Garner HE; Cregan SP Cell Death Differ; 2021 May; 28(5):1627-1643. PubMed ID: 33277577 [TBL] [Abstract][Full Text] [Related]
40. Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition. Stoll AC; Kemp CJ; Patterson JR; Kubik M; Kuhn N; Benskey M; Duffy MF; Luk KC; Sortwell CE J Neuroinflammation; 2024 Apr; 21(1):108. PubMed ID: 38664840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]